About Stevanato Group SpA 
Stevanato Group SpA
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available
Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Domestic Funds
Domestic Funds
Held in 46 Schemes (51.43%)
Foreign Institutions
Held by 71 Foreign Institutions (21.03%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
No Data
Revenue and Profits:
Net Sales:
403 Million
(Quarterly Results - Dec 2025)
Net Profit:
55 Million
Pharmaceuticals & Biotechnology
USD 4,191 Million (Small Cap)
28.00
NA
0.00%
0.23
8.76%
2.48






